The Company develops and markets aesthetic treatment systems to perform non-invasive procedures to remove hair, treat vascular lesions, rejuvenate skin through the treatment of shallow vascular lesions and temporarily reduce the appearance of cellulite.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
screener
CAPS Rating
4 - 5 on 2009-09-02
4 - 5 on 2008-12-31
% Below 12 Month High >= 50
4 Week Price Change %5 - 75
Price-to-Earnings (TTM) <= 15
Price-to-Sales (TTM) <= 10
Price-to-Book (TTM) <= 10
Current Ratio >= 1
Gross Margin >= 20